104 related articles for article (PubMed ID: 38796779)
1. Checkpoint inhibitor-related myasthenia-myocarditis-myositis overlap syndrome in the orbit.
Park BJ; Warning AW; Akella SS
Orbit; 2024 May; ():1-7. PubMed ID: 38796779
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
Pathak R; Katel A; Massarelli E; Villaflor VM; Sun V; Salgia R
Oncologist; 2021 Dec; 26(12):1052-1061. PubMed ID: 34378270
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
Lipe DN; Galvis-Carvajal E; Rajha E; Wechsler AH; Gaeta S
Am J Emerg Med; 2021 Aug; 46():51-55. PubMed ID: 33721590
[TBL] [Abstract][Full Text] [Related]
4. Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature.
Cuenca JA; Hanmandlu A; Wegner R; Botdorf J; Tummala S; Iliescu CA; Nates JL; Reddy DR
BMC Anesthesiol; 2023 Sep; 23(1):310. PubMed ID: 37700240
[TBL] [Abstract][Full Text] [Related]
5. Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature.
Yin B; Xiao J; Wang X; Li X; Guan Y; Chen J; Han P; Li K; Wang J
Front Med (Lausanne); 2022; 9():950801. PubMed ID: 36457566
[TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis.
Saito S; Hontsu S; Hiraoka J; Yamanaka A; Fujioka N; Shimada D; Okuda Y; Sugie K; Muro S
Intern Med; 2024 Apr; ():. PubMed ID: 38658343
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
Wai Siu DH; O'Neill RS; Harris CA; Wang J; Ardolino L; Downton T; Tong M; Hong JH; Chin V; Clingan PR; Aghmesheh M; Soudy H
Immunotherapy; 2022 May; 14(7):511-520. PubMed ID: 35321560
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series.
Longinow J; Zmaili M; Skoza W; Kondoleon N; Marquardt R; Calabrese C; Funchain P; Moudgil R
Cancer Med; 2023 Feb; 12(3):2281-2289. PubMed ID: 36128926
[TBL] [Abstract][Full Text] [Related]
9. Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor.
Ünlütürk Z; Karagülmez AM; Hayti B; Erdoğan Ç
J Neurosci Rural Pract; 2023; 14(1):143-144. PubMed ID: 36891103
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.
Deharo F; Carvelli J; Cautela J; Garcia M; Sarles C; Maues de Paula A; Bourenne J; Gainnier M; Bichon A
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233479
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis-A Case Series.
Aggarwal N; Bianchini D; Parkar R; Turner J
Case Rep Med; 2024; 2024():5399073. PubMed ID: 38585685
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report.
Basnet A; Sharma NR; Gautam S; Lamichhane S; Kansakar S; Tiwari K; Pokhrel M; Singh S
Clin Case Rep; 2024 Jun; 12(6):e8968. PubMed ID: 38863868
[TBL] [Abstract][Full Text] [Related]
13. Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series.
Weaver JM; Dodd K; Knight T; Chaudhri M; Khera R; Lilleker JB; Roberts M; Lorigan P; Cooksley T
Support Care Cancer; 2023 Aug; 31(9):518. PubMed ID: 37572133
[TBL] [Abstract][Full Text] [Related]
14. The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma.
Jeyakumar N; Etchegaray M; Henry J; Lelenwa L; Zhao B; Segura A; Buja LM
Case Reports Immunol; 2020; 2020():5126717. PubMed ID: 32695533
[TBL] [Abstract][Full Text] [Related]
15. Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review.
Chen Y; Jia Y; Liu Q; Shen Y; Zhu H; Dong X; Huang J; Lu J; Yin Q
Ann Palliat Med; 2021 Jul; 10(7):8512-8517. PubMed ID: 34263614
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
Niimura T; Zamami Y; Miyata K; Mikami T; Asada M; Fukushima K; Yoshino M; Mitsuboshi S; Okada N; Hamano H; Sakurada T; Matsuoka-Ando R; Aizawa F; Yagi K; Goda M; Chuma M; Koyama T; Izawa-Ishizawa Y; Yanagawa H; Fujino H; Yamanishi Y; Ishizawa K
J Clin Pharmacol; 2023 Apr; 63(4):473-479. PubMed ID: 36453166
[TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy.
Saygin D; Ghosh N; Reid P
J Clin Rheumatol; 2022 Oct; 28(7):367-373. PubMed ID: 35696731
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibition-Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade.
Nelke C; Pawlitzki M; Kerkhoff R; Schroeter CB; Aktas O; Neuen-Jacob E; Polzin A; Meuth SG; Ruck T
Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):. PubMed ID: 37884388
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Aldrich J; Pundole X; Tummala S; Palaskas N; Andersen CR; Shoukier M; Abdel-Wahab N; Deswal A; Suarez-Almazor ME
Arthritis Rheumatol; 2021 May; 73(5):866-874. PubMed ID: 33258544
[TBL] [Abstract][Full Text] [Related]
20. Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma.
Xing Q; Zhang ZW; Lin QH; Shen LH; Wang PM; Zhang S; Fan M; Zhu B
Ann Transl Med; 2020 Mar; 8(5):250. PubMed ID: 32309397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]